Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Muscular dystrophies with reduced glycosylation of alpha-dystroglycan (alpha-DG), commonly referred to as dystroglycanopathies, are a heterogeneous group of autosomal recessive conditions which include a wide spectrum of clinical severity. Reported phenotypes range from severe congenital onset Walker-Warburg syndrome (WWS) with severe structural brain and eye involvement, to relatively mild adult onset limb girdle muscular dystrophy (LGMD). Specific clinical syndromes were originally described in association with mutations in any one of six demonstrated or putative glycosyltransferases. Work performed on patients with mutations in the FKRP gene has identified that the spectrum of phenotypes due to mutations in this gene is much wider than originally assumed. To further define the mutation frequency and phenotypes associated with mutations in the other five genes, we studied a large cohort of patients with evidence of a dystroglycanopathy. Exclusion of mutations in FKRP was a prerequisite for participation in this study. Ninety-two probands were screened for mutations in POMT1, POMT2, POMGnT1, fukutin and LARGE. Homozygous and compound heterozygous mutations were detected in a total of 31 probands (34 individuals from 31 families); 37 different mutations were identified, of which 32 were novel. Mutations in POMT2 were the most prevalent in our cohort with nine cases, followed by POMT1 with eight cases, POMGnT1 with seven cases, fukutin with six cases and LARGE with only a single case. All patients with POMT1 and POMT2 mutations had evidence of either structural or functional central nervous system involvement including four patients with mental retardation and a LGMD phenotype. In contrast mutations in fukutin and POMGnT1 were detected in four patients with LGMD and no evidence of brain involvement. The majority of patients (six out of nine) with mutations in POMT2 had a Muscle-Eye-Brain (MEB)-like condition. In addition we identified a mutation in the gene LARGE in a patient with WWS. Our data expands the clinical phenotypes associated with POMT1, POMT2, POMGnT1, fukutin and LARGE mutations. Mutations in these five glycosyltransferase genes were detected in 34% of patients indicating that, after the exclusion of FKRP, the majority of patients with a dystroglycanopathy harbour mutations in novel genes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A child affected with ASD and moderate intellectual disability was found to have a homozygous missense change (p.R367H) in POMGNT1 (Table 1B; Figure S4). POMGNT1 is responsible for an inherited dystroglycanopathy characterized by brain malformation, intellectual disability, developmental delay, hypotonia, and myopia; interestingly, rare patients have been reported with severe autistic features (”
From Using Whole-Exome Sequencing to Identify Inherited Causes of Autism (2013) · cites this paper as Godfrey et al., 2007
Citations
Cites
Muscle Biopsy: A Practical Approach
Dubowitz, V., Sewry, C. A., Oldfors, A., & Lane, R. J. M. (2020) · Cited by 1,335
Self-citationAn ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy
Kobayashi, K., Nakahori, Y., Miyake, M., Matsumura, K., Kondo-Iida, E., Nomura, Y., Segawa, M., Yoshioka, M., Saito, K., Osawa, M., et al. (1998) · Nature · doi:10.1038/28653 · Cited by 802
Yoshida, A., Kobayashi, K., Manya, H., Taniguchi, K., Kano, H., Mizuno, M., Inazu, T., Mitsuhashi, H., Takahashi, S., Takeuchi, M., et al. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00070-3 · Cited by 706 · cited 2×
“These genes are thought to be involved in the addition of carbohydrate residues onto the -DG backbone either via the process of O-mannosylation (POMT1, POMT2, POMGnT1) (Yoshida et al., 2001; Manya et al., 2003; Akasaka-Manya et al., 2004) or via other not fully characterized mechanisms (fukutin, FKRP and LARGE) (de Pa…”
BackgroundSelf-citationBeltrán-Valero de Bernabé, D., Currier, S., Steinbrecher, A., Celli, J., van Beusekom, E., van der Zwaag, B., Kayserili, H., Merlini, L., Chitayat, D., Dobyns, W. B., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342975 · Cited by 685
Brockington, M., Blake, D. J., Prandini, P., Brown, S. C., Torelli, S., Benson, M. A., Ponting, C. P., Estournet, B., Romero, N. B., Mercuri, E., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/324412 · Cited by 603
Self-citationDystroglycan: from biosynthesis to pathogenesis of human disease
Barresi, R., & Campbell, K. P. (2006) · Journal of Cell Science · doi:10.1242/jcs.02814 · Cited by 596
Williamson, R. A., Henry, M. D., Daniels, K. J., Hrstka, R. F., Lee, J. C., Sunada, Y., Ibraghimov-Beskrovnaya, O., & Campbell, K. P. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.6.831 · Cited by 541
Brockington, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.25.2851 · Cited by 499
Self-citationLongman, C. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg307 · Cited by 416
Self-citationPOMT2 mutations cause α-dystroglycan hypoglycosylation and Walker-Warburg syndrome
van Reeuwijk, J., Janssen, M., van den Elzen, C., Beltran-Valero de Bernabé, D., Sabatelli, P., Merlini, L., Boon, M., Scheffer, H., Brockington, M., Muntoni, F., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.031963 · Cited by 414
Self-citationMutations in the FKRP gene can cause muscle-eye-brain disease and Walker–Warburg syndrome
Beltran-Valero de Bernabé, D., Voit, T., Longman, C., Steinbrecher, A., Straub, V, Yuva, Y., Herrmann, R., Sperner, J., Korenke, C., Diesen, C., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.013870 · Cited by 267
Self-citationPhenotypic spectrum associated with mutations in the fukutin‐related protein gene
Mercuri, E., Brockington, M., Straub, V., Quijano‐Roy, S., Yuva, Y., Herrmann, R., Brown, S. C., Torelli, S., Dubowitz, V., Blake, D. J., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10559 · Cited by 235
Self-citationClinical and genetic distinction between Walker–Warburg syndrome and muscle–eye–brain disease
Cormand, B., Pihko, H., Bayés, M., Valanne, L., Santavuori, P., Talim, B., Gershoni–Baruch, R., Ahmad, A., van Bokhoven, H., Brunner, H. G., et al. (2001) · Neurology · doi:10.1212/wnl.56.8.1059 · Cited by 182
Self-citationBalci, B., Uyanik, G., Dincer, P., Gross, C., Willer, T., Talim, B., Haliloglu, G., Kale, G., Hehr, U., Winkler, J., et al. (2005) · Neuromuscular Disorders · doi:10.1016/j.nmd.2005.01.013 · Cited by 180
Self-citationAbnormalities in α-Dystroglycan Expression in MDC1C and LGMD2I Muscular Dystrophies
Brown, S. C., Torelli, S., Brockington, M., Yuva, Y., Jimenez, C., Feng, L., Anderson, L., Ugo, I., Kroger, S., Bushby, K., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63160-4 · Cited by 176
Self-citationDefective glycosylation in muscular dystrophy
Muntoni, F., Brockington, M., Blake, D. J., Torelli, S., & Brown, S. C. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11397-3 · Cited by 170
Self-citationFukutin gene mutations in steroid‐responsive limb girdle muscular dystrophy
Godfrey, C., Escolar, D., Brockington, M., Clement, E. M., Mein, R., Jimenez‐Mallebrera, C., Torelli, S., Feng, L., Brown, S. C., Sewry, C. A., et al. (2006) · Annals of Neurology · doi:10.1002/ana.21006 · Cited by 163
Self-citationFukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness
Murakami, T., Hayashi, Y. K., Noguchi, S., Ogawa, M., Nonaka, I., Tanabe, Y., Ogino, M., Takada, F., Eriguchi, M., Kotooka, N., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20973 · Cited by 157
A homozygous nonsense mutation in the Fukutin gene causes a Walker-Warburg syndrome phenotype
de Bernabé, D. B.-V., van Bokhoven, H., van Beusekom, E., van den Akker, W. M. R., Kant, S. G., Dobyns, W. B., Cormand, B., Currier, S., Hamel, B. C. J., Talim, B., et al. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.11.845 · Cited by 153
Self-citationFKRP gene mutations cause congenital muscular dystrophy, mental retardation, and cerebellar cysts
Topaloğlu, H., Brockington, M., Yuva, Y., Talim, B., Haliloğlu, G., Blake, D. R., Torelli, S., Brown, S., & Muntoni, F. (2003) · Neurology · doi:10.1212/01.wnl.0000052996.14099.dc · Cited by 129
Self-citationGlyc‐O‐genetics of Walker–Warburg syndrome
van Reeuwijk, J., Brunner, H. G., & van Bokhoven, H. (2004) · Clinical Genetics · doi:10.1111/j.1399-0004.2004.00368.x · Cited by 115
Spectrum of Brain Changes in Patients With Congenital Muscular Dystrophy and FKRP Gene Mutations
Mercuri, E. M., Topaloğlu, H., Brockington, M., Berardinelli, A. L., Pichiecchio, A., Santorelli, F. M., Rutherford, M., Talim, B., Ricci, E., Voït, T., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.2.251 · Cited by 105
Self-citationBrockington, M., Torelli, S., Prandini, P., Boito, C., Dolatshad, N. F., Longman, C., Brown, S. C., & Muntoni, F. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi062 · Cited by 103 · cited 1×
“, 2004) or via other not fully characterized mechanisms (fukutin, FKRP and LARGE) (de Paula et al., 2003; Brown et al., 2004; Brockington et al., 2005; Xiong et al., 2006).”
BackgroundSelf-citationLoss-of-function of an N-acetylglucosaminyltransferase, POMGnT1, in muscle–eye–brain disease
Manya, H., Sakai, K., Kobayashi, K., Taniguchi, K., Kawakita, M., Toda, T., & Endo, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00924-0 · Cited by 97
Physical and Functional Association of Human Protein O-Mannosyltransferases 1 and 2
Akasaka‐Manya, K., Manya, H., Nakajima, A., Kawakita, M., & Endo, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601091200 · Cited by 92
Asymptomatic carriers for homozygous novel mutations in the FKRP gene: the other end of the spectrum
Paula, F., Vieira, N. M., Starling, A., Yamamoto, L. U., Lima, B., Pavanello, R. C. M., Vainzof, M., Nigro, V., & Zatz, M. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201066 · Cited by 81
Molecular interaction between fukutin and POMGnT1 in the glycosylation pathway of α-dystroglycan
Xiong, H., Kobayashi, K., Tachikawa, M., Manya, H., Takeda, S., Chiyonobu, T., Fujikake, N., Wang, F., Nishimoto, A., Morris, G. E., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.129 · Cited by 73
POMGnT1 mutation and phenotypic spectrum in muscle-eye-brain disease
Diesen, C., Saarinen, A., Pihko, H., Rosenlew, C., Cormand, B., Dobyns, W. B., Dieguez, J., Valanne, L., Joensuu, T., & Lehesjoki, A. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.020701 · Cited by 72
Mutations inPOMT1 are found in a minority of patients with Walker-Warburg syndrome
Currier, S., Lee, C. K., Chang, B. S., Bodell, A., Pai, G. S., Job, L., Lagae, L. G., Al-Gazali, L. I., Eyaid, W., Enns, G., et al. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30487 · Cited by 58
Fukuyama‐type congenital muscular dystrophy (FCMD) and α‐dystroglycanopathy
Toda, T., Kobayashi, K., Takeda, S., Sasaki, J., Kurahashi, H., Kano, H., Tachikawa, M., Wang, F., Nagai, Y., Taniguchi, K., et al. (2003) · Congenital Anomalies · doi:10.1111/j.1741-4520.2003.tb01033.x · Cited by 55
Akasaka‐Manya, K., Manya, H., Kobayashi, K., Toda, T., & Endo, T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.129 · Cited by 37
Harel, T., Goldberg, Y., Shalev, S. A., Chervinsky, I., Ofir, R., & Birk, O. S. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201087 · Cited by 35
A novel FKRP gene mutation in a Taiwanese patient with limb-girdle muscular dystrophy 2I
Lin, Y.-C., Murakami, T., Hayashi, Y. K., Nishino, I., Nonaka, I., Yuo, C., & Jong, Y. (2006) · Brain and Development · doi:10.1016/j.braindev.2006.09.006 · Cited by 19
Brockington, M., & Muntoni, F. (2005) · PubMed · Cited by 15
Self-citationVieira, N. M., Schlesinger, D., Paula, F., Vainzof, M., & Zatz, M. (2006) · Neuromuscular Disorders · doi:10.1016/j.nmd.2006.08.007 · Cited by 12
Cited by
Prevalence of Muscular Dystrophies: A Systematic Literature Review
Theadom, A., Rodrigues, M., Roxburgh, R., Balalla, S., Higgins, C., Bhattacharjee, R., Jones, K., Krishnamurthi, R., & Feigin, V. (2014) · Neuroepidemiology · doi:10.1159/000369343 · Cited by 2,046
A developmental and genetic classification for malformations of cortical development: update 2012
Barkovich, A. J., Guerrini, R., Kuzniecky, R. I., Jackson, G. D., & Dobyns, W. B. (2012) · Brain · doi:10.1093/brain/aws019 · Cited by 1,104
Mercuri, E., Bönnemann, C. G., & Muntoni, F. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32910-1 · Cited by 551
Self-citationUsing Whole-Exome Sequencing to Identify Inherited Causes of Autism
Yu, T. W., Chahrour, M. H., Coulter, M. E., Jiralerspong, S., Okamura-Ikeda, K., Ataman, B., Schmitz-Abe, K., Harmin, D. A., Adli, M., Malik, A. N., et al. (2013) · Neuron · doi:10.1016/j.neuron.2012.11.002 · Cited by 442
“The p.R367H missense variant in this patient disrupts a highly conserved residue, and this exact allele has been reported as causative in a patient with relatively mild clinical disease, as a compound heterozygousmutation in combination with a splice site mutation (Godfrey et al., 2007).”
BackgroundMercuri, E., & Muntoni, F. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61897-2 · Cited by 434
Self-citation
Metadata
- Authors
- Godfrey, C., Clement, E., Mein, R., Brockington, M., Smith, J., Talim, B., Straub, V., Robb, S., Quinlivan, R., Feng, L., Jimenez-Mallebrera, C., Mercuri, E., Manzur, A. Y., Kinali, M., Torelli, S., Brown, S. C., Sewry, C. A., Bushby, K., Topaloglu, H., North, K., Abbs, S., & Muntoni, F.
- Affiliations
- The University of Sydney (AU)
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-10-01
- Volume
- 130
- Issue
- 10
- Pages
- 2725-2735
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2128173275
- Cited by
- 441
- References
- 35
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 13 · 2023: 21 · 2022: 13 · 2021: 24 · 2020: 23 · 2019: 21 · 2018: 23 · 2017: 21 · 2016: 22 · 2015: 24 · 2014: 33 · 2013: 34 · 2012: 35
- FWCI
- 11.12
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Hacettepe University Institutional Repository (hacettepe.edu.tr) (submittedVersion, other-oa)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- dystroglycanopathies, alpha-dystroglycan glycosylation, genotype-phenotype correlation, POMT1, POMT2, POMGnT1, fukutin, LARGE, limb-girdle muscular dystrophy, Walker-Warburg syndrome, compound heterozygosity
- MeSH terms
- Child, Preschool, DNA Mutational Analysis, Glycosylation, Humans, Infant, Male, Mannosyltransferases, Membrane Proteins, Muscular Dystrophies, Mutation, Phenotype, Cohort Studies, N-Acetylglucosaminyltransferases, Dystroglycans, Muscular Dystrophies, Limb-Girdle
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.